FDA Inspection
Nectar Lifesciences LimitedNectar Lifesciences Limited – FDA Inspection, Mar 10, 2023
Record Details
This FDA Inspection record concerns Nectar Lifesciences Limited, with an inspection on March 10, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 60d76fd7-7e2d-491f-a835-c718e18c3eaa
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1200622
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
14- 21 CFR 211.42(c)(10)(vi)Equipment to control conditions
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.194(a)(2)Suitability of testing methods verified
- 21 CFR 211.192Written record of investigation incomplete
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.192Written record of investigation incomplete
- 21 CFR 211.194(a)(2)Suitability of testing methods verified
Showing 10 of 14 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Nectar Lifesciences Limited
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 21, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Nectar Lifesciences Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.